OmniActive Health Technologies

OmniActive Health Technologies is an India-based specialty and botanical-actives ingredient supplier with branded ingredients including CurcuWIN (curcumin), Lutemax 2020 and Lutemax Free Lutein (carotenoids), and UltraSOL nutrient-delivery technology. Active M&A signal as of Q1 2026: Swedish private equity firm EQT is the sole bidder following rejection of a competing Temasek/Novo Holdings offer; valuation gap reported (~$1B hoped vs lower bids). Active patent enforcement: OmniActive filed a US patent infringement lawsuit against Bio-gen Extracts (India) in the Eastern District of Texas on 2025-06-23 (U.S. Patent No. 10,532,035, Lute-gen vs Lutemax). Both signals reflect a healthy operating company defending IP and exploring exit — not enforcement risk against OmniActive.

undefined, IN

Directory Listing · Records Reviewed

Public records and independent sources have been reviewed.

What this means →

MOQ: Not publicly disclosed
LEAD TIME: Not publicly disclosed

Request a free introWhy this vendor was included · read the editor's call

Editor’s call

Codex Phase A surfaced via SupplySide coverage with M&A + patent-litigation pre-flagged. Crow Phase B WebSearch confirmed EQT sole-bidder status as of Q1 2026 (Whalesbook) and patent suit filing against Bio-gen Extracts (PR Newswire). OmniActive is an established branded-ingredient supplier; M&A in flight is a refresh trigger, not a disqualifier. GRAS claims for CurcuWIN and Lutemax remain stale trade-press references not added to certifications[] because GRAS is a regulatory notice not a third-party certification; Phase B did not locate direct FDA GRAS Notice entries. Only Non-GMO Project Verified entry in certifications[] (self-reported, NutraIngredients 2018 trade-press). Listed at trust tier 2 reflecting the all-self-reported certifications[] composition per IR validator rules. Assessment next review accelerated to 2026-10-26 (5 months) to coincide with expected EQT deal resolution window.

Greg
founder of Inventory Ready · sole reviewer

§1Editorial assessment

GRAS (Generally Recognized as Safe)Ingredient Sourcing Identity Testing

§2Our review

The six checks in our review, applied before any name appears in the directory. Each check is auto-derived from public evidence on this profile.

§3Inspection history

§4Certifications

0 of 1 certification independently confirmed. What this means

Non-GMO Project Verified(Self-Reported)

§5Capability matrix

PRODUCT TYPES: CurcuWIN (curcumin) · Lutemax 2020 + Lutemax Free Lutein (carotenoids) · UltraSOL nutrient-delivery technology · Specialty and botanical actives
CAPABILITIES: Specialty and botanical active ingredients · CurcuWIN curcumin ingredient · Lutemax carotenoid ingredients · UltraSOL nutrient-delivery technology · Sports, eye-health and active-nutrition ingredient applications

§6Sources

Codex Phase A discovery JSON(2026-05-26)
Crow Phase B verification research file(2026-05-26)
OmniActive CurcuWIN product page(2026-05-26)
Whalesbook 2026 EQT-OmniActive M&A coverage(2026-05-26)
PR Newswire OmniActive v Bio-gen patent suit (2025-06-23)(2026-05-26)

§7 · What we don't know

Current FDA GRAS Notice Inventory entries (if any) for Lutemax 2020 and CurcuWIN
EQT acquisition close-or-collapse status
ENovate Biolife portfolio integration scope

Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.

What We Couldn't Verify

Active M&A negotiations with EQT as of Q1 2026 — entity ownership may change post-deal-close; refresh entity status after Q3 2026 or upon deal closure (per Whalesbook 2026 reporting)
Active US patent litigation (OmniActive v. Bio-gen Extracts, ED-TX, 2025-06-23) — not a strike against OmniActive itself but indicates active IP enforcement environment
Self-affirmed GRAS for CurcuWIN (NutraIngredients 2016) and FDA GRAS no-objection for Lutemax 2020 (NutraIngredients 2012) are stale trade-press references not added to certifications[] because GRAS is a regulatory notice not a third-party certification + Phase B did not locate current FDA GRAS Notice Inventory entries. Captured in assessmentRationale + sources[].
OmniActive recently acquired ENovate Biolife (per PR Newswire); ingredient portfolio scope may expand or shift
Discovery surface is SupplySide Global exhibitor (paid commercial relationship); direct OmniActive certification directory cross-check incomplete in Phase B

Last reviewed: May 26, 2026

For the check-by-check breakdown that produces this vendor's score, see our scoring framework. The connection map between OmniActive Health Technologies and other vendors, capabilities, and certifications is in the manufacturer atlas.

Interested in OmniActive Health Technologies?

Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.

Tell Us About Your Project